Provided by Tiger Trade Technology Pte. Ltd.

FOSUN PHARMA

16.330
-0.180-1.09%
Volume:6.40M
Turnover:104.36M
Market Cap:43.39B
PE:11.00
High:16.500
Open:16.440
Low:16.100
Close:16.510
52wk High:28.232
52wk Low:14.505
Shares:2.66B
HK Float Shares:539.00M
Volume Ratio:0.96
T/O Rate:1.19%
Dividend:0.46
Dividend Rate:2.79%
EPS(LYR):1.485
ROE:6.95%
ROA:1.40%
PB:0.76
PE(LYR):11.00
PS:0.87

Loading ...

FOSUN PHARMA Reports 2025 Results: Revenue Hits 41.7B Yuan with 21.7% Net Profit Growth

Deep News
·
Mar 25

FOSUN PHARMA Shares Surge Over 5% as Annual Net Profit Climbs 21.69% to 3.37 Billion Yuan

Deep News
·
Mar 25

Stock Track | Fosun Pharma Soars 5.21% Intraday on Strong 2025 Earnings and Dividend Announcement

Stock Track
·
Mar 25

FOSUN PHARMA Declares Final Dividend of HK$0.39 Per Share

Stock News
·
Mar 25

Fosun Pharma Announces RMB0.39 Final Dividend for FY2025

Bulletin Express
·
Mar 25

Fosun Pharma 2025 Results: Net Profit Up 21.69%, Innovative-Drug Sales Surge 29.59%

Bulletin Express
·
Mar 25

Shanghai Fosun Pharma - Proposed to Distribute Cash Dividend of RMB0.39 for Each Ordinary Share

THOMSON REUTERS
·
Mar 25

Press Release: Fosun Pharma Announces 2025 Annual Results

Dow Jones
·
Mar 24

FOSUN PHARMA Subsidiaries to Expand Financing Through Leasing Agreements

Stock News
·
Mar 24

Fosun Pharma Reports 2025 Results: Dual Engines of Innovative Drugs and Globalization Drive High-Quality Growth

Stock News
·
Mar 24

Fosun Pharma (02196) Subsidiary Obtains NMPA Green Light for Sodium Thiosulfate Injection

Bulletin Express
·
Mar 20

FOSUN PHARMA Subsidiary Gains Approval for Phase I Trial of HLX18 in Solid Tumors

Stock News
·
Mar 20

FOSUN PHARMA's Sodium Thiosulfate Injection Receives Regulatory Approval

Stock News
·
Mar 20

Fosun Pharma (02196): Subsidiary MicroH Therapeutics Secures NMPA Green Light for Phase I Trial of LBP-ShC4 Live Biotherapeutic

Bulletin Express
·
Mar 16

FOSUN PHARMA's HLX07 Combined with Serplulimab Injection and Chemotherapy Cleared for Clinical Trial in Advanced Squamous Non-Small Cell Lung Cancer

Stock News
·
Mar 16

Fosun Pharmaceutical Gets Chinese Regulator's Nod for Clinical Trials of Blood Cancer Drug

MT Newswires Live
·
Mar 16